Faculty Publications
As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.
Total number of publications: 7,082
Enter a faculty name:
or browse faculty by school:
Administrative Offices
Graduate Schools
Health Sciences
Lander Colleges
Law Center
New York School of Career and Applied Studies (NYSCAS)
Touro University System
New York Medical College (NYMC)
Touro University California
Touro University Nevada
Chu, Y., Lee, F., Hamby, C., Misarti, J., Hang, B., Ayello, J., . . . Cairo, M. (2016). Regulation of cytokine release and anti-tumor effect of anti-CD20 CAR modified expanded natural killer cells by Alt-803, an IL-15 superagonist. Experimental Hematology, 44(9), S64. doi:10.1016/j.exphem.2016.06.107
Cimica, V., Boigard, H., Bhatia, B., Fallon, J. T., Alimova, A., Gottlieb, P., & Galarza, J. M. (2016). Novel respiratory syncytial virus-like particle vaccine composed of the postfusion and prefusion conformations of the F glycoprotein. Clinical and Vaccine Immunology, 23(6), 451-459. doi:10.1128/CVI.00720-15
Clarke, D. K., Hendry, R. M., Singh, V., Rose, J. K., Seligman, S. J., Klug, B., . . . Brighton Collaboration Viral Vector Vaccines Safety Working Group. (2016). Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment. Vaccine, 34(51), 6597-6609. doi:10.1016/j.vaccine.2016.06.071
Condit, R. C., Williamson, A. L., Sheets, R., Seligman, S. J., Monath, T. P., Excler, J. L., . . . Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). (2016). Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains. Vaccine, 34(51), 6610-6616. doi:10.1016/j.vaccine.2016.04.060
Dattwyler, R. J., & Arnaboldi, P. M. (2014). Comparison of Lyme disease serologic assays and Lyme specialty laboratories. Clinical Infectious Diseases, 59(12), 1711-1713. doi:10.1093/cid/ciu705
Diana, J. S., Egna, H. S., Chopin, T., Peterson, M. S., Cao, L., Pomeroy, R., . . . Cabello, F. C. (2013). Responsible aquaculture in 2050: Valuing local conditions and human innovations will be key to success. Bioscience, 63(4), 255-262. doi:10.1525/bio.2013.63.4.5
Dotson, R. J., Rabadi, S. M., Westcott, E. L., Bradley, S., Catlett, S. V., . . . Bakshi, C. S., & Malik, M. (2013). Repression of inflammasome by Francisella tularensis during early stages of infection. Journal of Biological Chemistry, 288(33), 23844-23857. doi:10.1074/jbc.M113.490086
Doyle, T. M., Li, C., Bucher, D. J., Hashem, A. M., Van Domselaar, G., Wang, J., . . . Li, X. (2013). A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains. Biochemical and Biophysical Research Communications, 441(1), 226-229. doi:10.1016/j.bbrc.2013.10.041
George, A. L., Suriano, R., Rajoria, S. , Geliebter, J., Arnold, A. N., Wallack, M., . . . Tiwari, R. K. (2015). PLX4032 mediated melanoma associated antigen potentiation in patient derived primary melanoma cells. Journal of Cancer, 6(12), 1320-1330. doi:10.7150/jca.11126
Goralski, T. D., Dewan, K. K., Alumasa, J. N., Avanzato, V., Place, D. E., Markley, R. L., . . . Bakshi, C. S. (2016). Inhibitors of ribosome rescue arrest growth of Francisella tularensis at all stages of intracellular replication. Antimicrobial Agents and Chemotherapy, 60(6), 3276-3282. doi:10.1128/AAC.03089-15
Hanly, E. K., Bednarczyk, R. B., Moscatello, A. L., Halicka, H. D., Geliebter, J., Darzynkiewicz, Z., . . . Tiwari, R. K. (2015). mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib. Oncotarget, 6(37), 39702-39713. doi:10.18632/oncotarget.4052
Hanly, E. K., Darzynkiewicz, Z., & Tiwari, R. K. (2015). Biguanides and targeted anti-cancer treatments. Genes & Cancer, 6(3-4), 82-83. doi:10.18632/genesandcancer.59
Hanly, E. K., Darzynkiewicz, Z., Zhao, H., Suriano, R., Shin, E. J., Geliebter, J., . . . Tiwari, R. K. (2014). Disruption of mutated BRAF signaling modulates thyroid cancer phenotype. BMC Research Notes, 7, 187. doi:10.1186/1756-0500-7-187
Hanly, E. K., Tuli, N. Y., Suriano, R., Geliebter, J., Moscatello, A. L., Darzynkiewicz, Z.,. . . Tiwari, R. K. (2015). Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells. Oncotarget, 7(8), 8676-8687. doi:10.18632/oncotarget.6779
Hanly, E. K., Tuli, N. Y., Suriano, R., Geliebter, J., Moscatello, A. L., Darzynkiewicz, Z.,. . . Tiwari, R. K. (2016). Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells. Oncotarget, 7(8), 8676-8687. doi:10.18632/oncotarget.6779
Horowitz, H. W., Aguero-Rosenfeld, M. E., Holmgren, D., McKenna, D., Schwartz, I., Cox, M. E., . . . Wormser, G. P. (2013). Lyme disease and human granulocytic anaplasmosis coinfection: Impact of case definition on coinfection rates and illness severity. Clinical Infectious Diseases, 56(1), 93-99. doi:10.1093/cid/cis852
Huang, W., Ojaimi, C., Fallon, J. T., Travisany, D., Maass, A., Godfrey, H. P., . . . Cabello, F. C. (2015). Genome sequence of Borrelia chilensis VA1, a South American member of the Lyme borreliosis group. Genome Announcements, 3(1), e01535-14. doi:10.1128/genomeA.01535-14
Ivanova, L. B., Tomova, A., Gonzalez-Acuna, D., Murua, R., Daniels, T. J., Godfrey, H. P., . . . Cabello, F. C. (2014). Borrelia chilensis, a new member of the Borrelia burgdorferi sensu lato complex that extends the range of this genospecies in the Southern Hemisphere. Environmental Microbiology, 16(4), 1069-1080. doi:10.1111/1462-2920.12310
Iyer, R., & Schwartz, I. (2016). Microarray-based comparative genomic and transcriptome analysis of Borrelia burgdorferi. Microarrays, 5(2), 9. doi:10.3390/microarrays5020009
Iyer, R. B., Mukherjee, P., Wang, K., Simons, J., Wormser, G. P., & Schwartz, I. (2013). Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability. Journal of Clinical Microbiology, 51(3), 857-862. doi:10.1128/JCM.02785-12
Iyer, R., Caimano, M. J., Luthra, A., Axline Jr., D., Corona, A., Iacobas, D. A., . . . Schwartz, I. (2015). Stage-specific global alterations in the transcriptomes of Lyme disease spirochetes during tick feeding and following mammalian host adaptation. Molecular Microbiology, 95(3), 509-538. doi:10.1111/mmi.12882
Jackson, S., Coulthwaite, L., Loewy, Z. G., Scallan, A., & Verran, J. (2014). Biofilm development by blastospores and hyphae of candida albicans on abraded denture acrylic resin surfaces. The Journal of Prosthetic Dentistry, 112(4), 988-993. doi:10.1016/j.prosdent.2014.02.003
Katz, G., Benkarroum, Y., Wei, H., Rice, W. J., Bucher, D., Alimova, A., . . . Gottlieb, P. (2014). Morphology of influenza B/Lee/40 determined by cryo-electron microscopy. PLoS One, 9(2), e88288. doi:10.1371/journal.pone.0088288
Khatchikian, C. E., Nadelman, R. B., Nowakowski, J., Schwartz, I., Levy, M. Z., Brisson, D., & Wormser, G. P. (2015). Public health impact of strain specific immunity to Borrelia burgdorferi. BMC Infectious Diseases, 15, 472. doi:10.1186/s12879-015-1190-7
Khatchikian, C. E., Nadelman, R. B., Nowakowski, J., Schwartz, I., Wormser, G. P., & Brisson, D. (2014). Evidence for strain-specific immunity in patients treated for early Lyme disease. Infection and Immunity, 82(4), 1408-1413. doi:10.1128/IAI.01451-13
